Correspondence 0001193125-23-152982 from Cue Biopharma, Inc. (CUE)
Cue Biopharma, Inc.
Date: May 24, 2023 · CIK: 0001645460 · Accession: 0001193125-23-152982
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271786
Letter
CUE BIOPHARMA, INC.
40 Guest Street
Boston, Massachusetts 02135
May 24, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance, Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
Re:
Cue Biopharma, Inc.
Registration Statement on Form S-3
Filed May 9, 2023
File No. 333-271786
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cue Biopharma, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-271786), so that it may become effective at 4:30 p.m. Eastern time on May 26, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the Staff.
Very truly yours,
CUE BIOPHARMA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP CUE BIOPHARMA, INC. 40 Guest Street Boston, Massachusetts 02135 May 24, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance, Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes Re: Cue Biopharma, Inc. Registration Statement on Form S-3 Filed May 9, 2023 File No. 333-271786 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cue Biopharma, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-271786), so that it may become effective at 4:30 p.m. Eastern time on May 26, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the Staff. Very truly yours, CUE BIOPHARMA, INC. By: /s/ Kerri-Ann Millar Name: Kerri-Ann Millar Title: Chief Financial Officer